feedburner

Enter your email address:

Delivered by FeedBurner

Glenmark Pharma gets USFDA nod for seizure treatment drug

Glenmark Pharmaceuticals Ltd has received final approval from the
United States Food and Drug Administration (USFDA) for Topiramate
extended-release capsules USP in the strengths of 25 mg, 50 mg, 100
mg, 150 mg, and 200 mg, Glenmark said in a regulatory filing.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-usfda-nod-for-seizure-treatment-drug/articleshow/80662988.cms



0 comments:

Post a Comment